Newsroom | 38858 results

DUBLIN--(BUSINESS WIRE)--The "X-Ray Inspection System Market - Global Forecast 2025-2032" has been added to ResearchAndMarkets.com's offering. Market research reveals the X-Ray Inspection System Market is poised for significant growth, projected to increase from USD 1.63 billion in 2024 to USD 2.59 billion by 2032 at a CAGR of 5.96%. As quality control and safety standards become more stringent across industries such as aerospace, automotive, and pharmaceuticals, X-Ray inspection systems have e...

NOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (OTCQB: QTIH) (“QT Imaging” or the “Company”), a medical device company engaged in research, development, and commercialization of innovative body imaging systems, today confirms that it finalized the shipment of 40 scanners and met its revenue guidance of more than $18 million in 2025. “2025 was a transitional year for QT Imaging as we moved from early commercialization to scaled execution. We met our objectives and shipped scanners in...

BOCA RATON, Floride--(BUSINESS WIRE)--Cataltheia Group et sa filiale américaine Bruno Vision Care LLC, leader dans le domaine de l’innovation en matière de santé oculaire, ont annoncé aujourd’hui que la Food and Drug Administration (FDA) américaine avait autorisé la première et unique lentille de contact souple (hydrophile) jetable à usage quotidien pour la presbytie utilisant la technologie optique brevetée Extended Depth of Focus (EDOF), permettant ainsi sa commercialisation aux États-Unis. D...

BOCA RATON, Fla.--(BUSINESS WIRE)--The Cataltheia Group e la sua controllata, Bruno Vision Care LLC, azienda leader nell'innovazione della salute degli occhi, oggi ha annunciato che la Food and Drug Administration (FDA) statunitense ha approvato la prima e unica Daily Disposable Soft (Hydrophilic) Contact Lens per la presbiopia che utilizza la tecnologia brevettata di progettazione ottica Extended Depth of Focus (EDOF), dando il via alla distribuzione commerciale negli Stati Uniti. Deseyne® off...

BOCA RATÓN, Florida--(BUSINESS WIRE)--Cataltheia Group y su filial en los Estados Unidos, Bruno Vision Care LLC, líder en innovación en salud ocular, anunciaron hoy que la Administración de Alimentos y Medicamentos de los Estados Unidos (FDA) ha autorizado la primera y única lente de contacto blanda (hidrofílica) diaria y desechable para la presbicia que utiliza una tecnología óptica patentada de profundidad de foco extendida (EDOF, por sus siglas en inglés), cuya distribución comercial ahora s...

BOCA RATON, Fla.--(BUSINESS WIRE)--De Cataltheia Group en Bruno Vision Care LLC, de Amerikaanse dochteronderneming van het bedrijf en leider op gebied van innovatie voor de gezondheid van de ogen, maakten vandaag bekend dat de Amerikaanse FDA (U.S. Food & Drug Administration) de eerste en enige Daily Disposable Soft (hydrofiele) contactlens voor presbyopie heeft goedgekeurd, een contactlens die gebruik maakt van de gepatenteerde EDOF (Extended Depth of Focus) optische ontwerptechnologie. Da...

BOCA RATON, Fla.--(BUSINESS WIRE)--Die Cataltheia Group und ihre US-Tochtergesellschaft Bruno Vision Care LLC, ein führendes Unternehmen im Bereich der Augenheilkunde, gaben heute bekannt, dass die US-amerikanische Arzneimittelbehörde FDA (Food and Drug Administration) die erste und einzige weiche (hydrophile) Einweg-Tageskontaktlinse für Presbyopie zugelassen hat, die die patentierte optische EDOF-Technologie (Extended Depth of Focus) nutzt und damit den kommerziellen Vertrieb in den Vereinigt...

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC) (the “Company”), the world’s largest provider of health care solutions to office-based dental and medical practitioners, today announced that it expects to appoint the Company’s next CEO by mid-January 2026. Philip A. Laskawy, Lead Director for Henry Schein said, “We are pleased with the progress we have made in our search for Henry Schein’s next CEO. The search process is nearing completion but will not be finalized before year...

BOCA RATON, Fla.--(BUSINESS WIRE)--The Cataltheia Group and its U.S. subsidiary, Bruno Vision Care LLC, a leader in eye health innovation, today announced that the U.S. Food and Drug Administration (FDA) has cleared the first and only Daily Disposable Soft (Hydrophilic) Contact Lens for Presbyopia utilizing patented Extended Depth of Focus (EDOF) optical design technology, enabling commercial distribution in the United States. Deseyne® delivers smooth, continuous focus across near, intermediate...

DUBLIN--(BUSINESS WIRE)--The "Direct-to-Consumer Genetic Testing Market - Global Forecast 2025-2032" report has been added to ResearchAndMarkets.com's offering. The direct-to-consumer genetic testing market is undergoing rapid transformation, driven by technological advancement, new regulatory dynamics, and changing consumer expectations. Senior leaders must navigate this evolving landscape by understanding underlying drivers influencing strategic positioning, operational resilience, and growth...